Business Context and Reporting Period
This Form 8-K is a current report filed by Tivic Health Systems, Inc. (not Valion Bio, Inc.) on May 20, 2025. The filing announces the scheduling of the Company's 2025 Annual Meeting of Stockholders and provides updated deadlines for stockholder proposals and director nominations.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
There are no material financial changes reported. The primary change is the rescheduling of the Annual Meeting to June 30, 2025, which is more than 30 days prior to the anniversary of the 2024 meeting. Consequently, the standard deadlines for stockholder proposals under Rule 14a-8 have been revised.
Guidance, Outlook, and Corporate Events
- Annual Meeting: Scheduled to be held virtually on June 30, 2025.
- Record Date: May 14, 2025.
- Proposal Deadline (Rule 14a-8): Stockholder proposals must be received by May 26, 2025.
- Director Nominations: Nominations and other business proposals must be received by May 26, 2025.
- Universal Proxy Notice: Stockholders intending to solicit proxies for director nominees other than the Company's nominees must provide notice by May 30, 2025.
- Management Commentary: The Company reserves the right to change the meeting date and/or record date. Adjournments or postponements will not extend the submission deadlines.
Key Facts for Investor Verification
- Verify the correct registrant name is Tivic Health Systems, Inc. (Ticker: TIVC), as the input metadata referenced "Valion Bio, Inc."
- Confirm the Annual Meeting date of June 30, 2025, and the virtual format.
- Note the strict deadline of May 26, 2025, for submitting Rule 14a-8 proposals and director nominations.
- Check for the upcoming preliminary and definitive proxy statements for details on matters to be voted upon.